July 30, 2013; 81 (5) Special Article
Evidence-based guideline: Treatment of tardive syndromes
Report of the Guideline Development Subcommittee of the American Academy of Neurology
Roongroj Bhidayasiri, Stanley Fahn, William J. Weiner, Gary S. Gronseth, Kelly L. Sullivan, Theresa A. Zesiewicz
First published July 29, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31829d86b6
Roongroj Bhidayasiri
From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
Stanley Fahn
From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
William J. Weiner
From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
Gary S. Gronseth
From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
Kelly L. Sullivan
From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
Theresa A. Zesiewicz
From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
Evidence-based guideline: Treatment of tardive syndromes
Report of the Guideline Development Subcommittee of the American Academy of Neurology
Roongroj Bhidayasiri, Stanley Fahn, William J. Weiner, Gary S. Gronseth, Kelly L. Sullivan, Theresa A. Zesiewicz
Neurology Jul 2013, 81 (5) 463-469; DOI: 10.1212/WNL.0b013e31829d86b6
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

Article Figures & Data
Additional Files
Data Supplement
One table, nine appendices, and references; two Microsoft Word files and four PDF files.
Neurology® data supplements are not copyedited before publication. Published editorials and translations have been copyedited.
© 2013 American Academy of Neurology.
Files in this Data Supplement:- Appendixes e-1 to e-5 - PDF file
- Appendix e-6 - PDF file
- Appendix e-7 - PDF file
- Appendixes e-8 to e-9 - PDF file
- e-References - Microsoft Word file
- Table e-1 - Microsoft Word file
PODCAST
Disputes & Debates: Rapid online correspondence
- Reply from the guideline authors
- Roongroj Bhidayasiri, Director and Associate Professor of Neurology, Chulalongkorn University, Department of Medicine, Bangkok, Thailandguidelines@aan.com
- Stanley Fahn, New York, NY; Gary S. Gronseth, Kansas City, KS; Kelly L. Sullivan, Tampa, FL; Theresa A. Zesiewicz, Tampa, FL
Submitted September 04, 2013 - Evidence-based guideline: Treatment of tardive syndromes Report of the Guideline Development Subcommittee of the American Academy of Neurology
- Vladimir Lerner, Director of psychiatric ward, Ben Gurion University of the Negev, Be'er Sheva, Israellernervld@yahoo.com
- Chanoch Miodownik, Vladimir Lerner, Be'er Sheva, Israel
Submitted August 21, 2013
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement